Drug Therapy

Latest research

1. Efficacy and safety of FOLFOX for Japanese patients with advanced biliary tract cancer as second-line or later chemotherapy (JON2107-B study)

   • Takeshi Terashima
   • Chigusa Morizane
   • Hiroaki Nagano

   in International Journal of Clinical Oncology

   Article 19 October 2025

   

2. An Implementation Science Assessment of Intranasal Esketamine’s Limited Integration into Mainstream Psychiatric Treatment

   • Benjamin Anderson
   • Megan O’Grady

   in The Journal of Behavioral Health Services & Research

   Article 19 October 2025

3. Pimavanserin

   in Reactions Weekly

   Article 18 October 2025

4. Early real-life outcomes of dupilumab and mepolizumab in patients with uncontrolled primary diffuse type 2 chronic rhinosinusitis

   • Tommaso Saccardo
   • Giuseppe Roccuzzo
   • Giancarlo Ottaviano

   in European Archives of Oto-Rhino-Laryngology

   Article Open access 18 October 2025

   

5. Selpercatinib

   in Reactions Weekly

   Article 18 October 2025

6. Cardiotoxicity Induced by Targeted Cancer Therapies: Understanding the Risks and Developing Solutions

   • Anchal Chhabra
   • Veerta Sharma
   • Thakur Gurjeet Singh

   in Cardiovascular Drugs and Therapy

   Article 18 October 2025

   

7. Cardiovascular Outcomes Among Patients with COPD Prescribed with LABA or LAMA: A Real-World Territory Wide Study

   • Chun Ka Wong
   • Eugene C. C. Cheng
   • Wang Chun Kwok

   in Advances in Therapy

   Article Open access 18 October 2025

   

8. Methadone

   in Reactions Weekly

   Article 18 October 2025

9. Proteasome inhibitors/Imides

   in Reactions Weekly

   Article 18 October 2025

10. Aripiprazole

    in Reactions Weekly

    Article 18 October 2025

11. Synergistic combination of the adrenergic antagonist SR59230A with common chemotherapeutic drugs and target therapies in cancer and endothelial cells

    • Arianna Bandini
    • Letizia Biso
    • Marco Scarselli

    in Investigational New Drugs

    Article 18 October 2025

    

12. Effectiveness of Patient-Directed Education to Sustain Deprescribing: A Pragmatic Trial

    • Katie Fitzgerald Jones
    • Kelly Stolzmann
    • Amy M. Linsky

    in Drugs & Aging

    Article 18 October 2025

    

13. CGRP-targeted therapy fulfilling the treatment gap in medication-underuse setting: a retrospective cohort study at a tertiary headache center in Thailand, a lower-middle-income country

    • Sirawit Roongrojwittayakul
    • Prakit Anukoolwittaya
    • Wanakorn Rattanawong

    in The Journal of Headache and Pain

    Article Open access 17 October 2025

    

14. Efficacy and Safety of Lorundrostat in Uncontrolled and/or Treatment Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    • Manahil Mubeen
    • Kuldeep Dalpat Rai
    • Sijan Poudel

    in High Blood Pressure & Cardiovascular Prevention

    Article 17 October 2025

    

15. Remdesivir’s effectiveness in treating severe COVID-19—a retrospective cohort from Pakistan

    • Jamil Muqtadir
    • Syed Ali Raza
    • Yameena Noman Khan

    in Discover Medicine

    Article Open access 17 October 2025

    

16. Antiviral strategies against H5N1: current options and emerging therapeutics

    • Cleo Anastassopoulou
    • Antonios-Periklis Panagiotopoulos
    • Athanasios Tsakris

    in Infection

    Article 17 October 2025

    

17. Drug repurposing in oncology: a systematic review of anticancer effects of Lanatoside C at the molecular level

    • Oluwatobi O. Olayode
    • Tolulope J. Oladosu
    • Blessing T. Ogunoye

    in BMC Cancer

    Article Open access 17 October 2025

    

18. Combined effects of 5-azacytidine and oleuropein on miR-149-3p, miR-375, miR-574-5p expression and apoptosis in acute myeloid leukemia (AML) cell lines HL-60 and THP-1

    • Shohre Karimi Kelaye
    • Bahareh Kazemi
    • Saeed Solali

    in Molecular Biology Reports

    Article 17 October 2025

    

19. Combination therapies for chronic hepatitis B in the era of emerging novel drugs

    • Dandan Weng
    • Chenxi Zhang
    • Qing Xie

    in Hepatology International

    Article Open access 17 October 2025

    

20. The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort

    • Patrick Silva
    • Marina A. Costa
    • Magda M. Santana

    in CNS Drugs

    Article Open access 17 October 2025

    

Related journals

• 

  Journal

  Drugs

  Drugspromotes optimum pharmacotherapy by providing a programme of review and original research articles on the most important aspects of clinical...

  Publishing model

  Hybrid

  Journal Impact Factor

  14.4 (2024)

  Downloads

  1,788,899 (2024)

  Submission to first decision(median)

  6 days

• 

  Journal

  Reactions Weekly

  Reactions Weeklyis the unique one-stop-shop for all your adverse drug event needs, bringing you up-to-the minute summaries of the world's adverse...

  Publishing model

  Subscription

  Downloads

  904,085 (2024)

• 

  Journal

  Cancer Chemotherapy and Pharmacology

  Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an...

  Publishing model

  Hybrid

  Journal Impact Factor

  2.3 (2024)

  Downloads

  808,308 (2024)

  Submission to first decision(median)

  4 days